The relative risk of ischemic cerebrovascular accident in patients with Von Willebrand disease

被引:2
|
作者
Olagunju, Abdulbaril [1 ]
Mihyawi, Nawfal [2 ]
Fath, Ayman R. [1 ]
Bhattarai, Bikash [3 ]
Eldaly, Abdullah S. [4 ]
Forst, Beani [1 ]
Mantha, Yogamaya [2 ]
Yeneneh, Beeletsega T. [5 ]
机构
[1] Creighton Univ, Dept Med, 350 W Thomas Rd, Phoenix, AZ 85013 USA
[2] Univ Texas San Antonio, Cardiol Dept, San Antonio, TX USA
[3] Valleywise Hlth Med Ctr, Dept Biostat, Phoenix, AZ USA
[4] Mayo Clin, Dept Plast Surg, Jacksonville, FL USA
[5] Creighton Univ, Dept Cardiovasc Dis, Phoenix, AZ 85013 USA
关键词
Von Willebrand disease; ischemic stroke; endothelium; smoking; blood group O; FACTOR LEVELS INCREASE; HEART-DISEASE; STROKE; ATHEROSCLEROSIS; MORTALITY; MARKERS;
D O I
10.1177/10815589221150642
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cerebrovascular accident (CVA) is one of the leading causes of death in the United States. Von Willebrand factor plays an important role in platelet activation and adhesion. It remains unclear whether Von Willebrand disease (vWD) is associated with a decreased risk of developing CVA. The study aimed to compare the relative risk (RR) of CVA in patients with and without vWD. We queried the National Inpatient Sample from 2009 to 2014 for discharge data and records for vWD and CVA using International Classification of Diseases, Ninth-Revision codes. The unadjusted and adjusted RR of CVA in patients with and without vWD were estimated using log-binomial model. Descriptive measures including means, medians, standard deviations, and range were presented based on normality test of continuous data. The prevalence of CVA was lower in patients with vWD than in those without vWD (1.31% vs 2.04%), with a RR of 0.64 (95% confidence interval (CI): 0.60-0.68). After adjusting for common CVA risk factors, the RR remained lower in vWD patients: 0.81 (95% CI: 0.76-0.86). vWD is associated with a lower RR of developing CVA. This suggests that deficiency of Von Willebrand factor is potentially protective against the development of CVA. To the best of our knowledge, this is the first study in humans to compare the RR of CVA in patients with and without vWD. Future studies are needed to explore causal relationships and therapeutic benefits.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 50 条
  • [21] von Willebrand Factor and von Willebrand Disease
    王兆钺
    血栓与止血学, 2005, (04) : 147 - 149
  • [22] Outcomes in patients with ischemic cerebrovascular disease
    Ishibashi, A
    Yokokura, Y
    STROKE, 2000, 31 (11) : 2790 - 2790
  • [23] Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency
    Chen, CI
    Federici, AB
    Cramer, EM
    Canciani, MT
    Harrison, P
    Zheng, SL
    Massé, JM
    Mannucci, PM
    Hayward, CPM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 20 - 28
  • [24] Investigation of von Willebrand factor gene mutations in Korean von Willebrand disease patients
    Song, Jaewoo
    Choi, Jong Rak
    Song, Kyung Soon
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (03): : 169 - 176
  • [25] ISCHEMIC CEREBROVASCULAR DISEASE - ASSESSMENT OF RISK FACTORS
    GERTLER, MM
    RUSK, HA
    WHITER, HH
    LEETMA, HE
    EHRENKRA.M
    GERIATRICS, 1968, 23 (03) : 135 - &
  • [26] SPECIFICITY OF RISK FACTORS IN ISCHEMIC CEREBROVASCULAR DISEASE
    GERTLER, MM
    LEETMA, HE
    SALUSTE, E
    COVALT, DA
    ROSENBER.J
    CIRCULATION, 1969, 40 (4S3) : II87 - &
  • [27] New risk factors in ischemic cerebrovascular disease
    Vera Acosta, H.
    Vera Cuesta, H.
    REVISTA MEXICANA DE NEUROCIENCIA, 2005, 6 (01): : 68 - 77
  • [28] Unusually large von Willebrand factor multimers are released in acute cerebrovascular disease
    Heywood, DM
    Catto, AJ
    Carter, AM
    Bamford, JM
    Grant, PJ
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2634 - P2634
  • [29] von Willebrand factor activity in patients with acute ischemic stroke
    Nomura, E
    Kohriyama, T
    Kozuka, K
    Kajikawa, H
    Nakamura, S
    STROKE, 2000, 31 (11) : 2800 - 2800
  • [30] Genotypic analysis of patients with von Willebrand Disease
    vanHeerde, Waander
    Simons, Annet
    Krouwel, Sandy
    Schoormans, Selene
    vanGorkom, Britta Laros
    Brons, Paul
    Schols, Saskia
    HAEMOPHILIA, 2018, 24 : 110 - 111